|This Slide: #65 of 100|
Slide #65. MGC Diagnostics — Medisoft SA
MGC Diagnostics (MGCD)
MGC Diagnostics Corp. (NASDAQ: MGCD) a leading global medical technologies company, today announced it has entered into a letter of intent to acquire Medisoft SA of Sorinnes, Belgium.
MGC Diagnostics is a medical technology company focused on cardiorespiratory health solutions. Co. designs and markets non-invasive cardiorespiratory diagnostic products through its Medical Graphics Corporation and Medisoft SA subsidiaries under the MGC Diagnostics and Medisoft brand and trade names. Co.'s primary products include: pulmonary function equipment, which diagnose lung diseases such as asthma or Chronic Obstructive Pulmonary Disease; and gas exchange testing products, which measure functional capacity, fitness or conditioning levels, evaluate prognostic criteria for surgical procedures as well as help physicians diagnose heart and lung diseases.
Open the MGCD Page at The Online Investor »